Description
SARS-CoV Spike Protein. Cat# abx060655. Supplier: abbexa.
SARS-CoV Spike Protein (Recombinant) is a infectious disease antigen or toxin. This is a protein corresponding to the C-terminal region of SARS-CoV Spike Protein.
Target | SARS-CoV Spike |
Origin | Virus |
Expression | Recombinant |
Tested Applications | ELISA, WB |
Host | E. coli |
Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Form | Liquid |
Purity | > 95% (10% PAGE, Coomassie staining) |
Purification | GS-4B Sepharose-Affinity Purification |
Storage | Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles. |
UniProt Primary AC | P59594 (UniProt, ExPASy) |
UniProt Secondary AC | Q6QU82, Q7T696, Q7TA19, Q7TFA2, Q7TFB1, Q80BV6 |
UniProt Entry Name | SPIKE_CVHSA |
Gene Symbol | S |
GeneID | 1489668 |
KEGG | vg:1489668 |
Molecular Weight | 37 kDa. May appear as multiple bands on SDS-PAGE (intact protein at 37 kDa, GST fusion protein at 26 kDa, and the Spike fragment at 11 kDa). |
Sequence Fragment | Contains a mosaic of the immunodominant regions of the C-terminal of the Spike protein. Not full-length spike protein. The exact sequence is proprietary. |
Tag | GST tag |
Buffer | 25 mM Tris-HCl, 0.4% Sarcosyl, 0.25% Triton-X100, 50% Glycerol. Does not contain preservatives. |
Specificity | Immunoreactive with SARS positive sera. |
Concentration | 1 mg/ml |
Directions for use | Centrifuge before opening to ensure complete recovery of vial contents. |
Availability | Shipped within 5-10 working days. |
Note | This product is for research use only.
Not for human consumption, cosmetic, therapeutic or diagnostic use. |